23May
20May
Interview with John O’Neil, Chief Scientific Officer of Xylyx
An inspiration and candid conversation between Dr. Mayasari Lim and upcoming 3DHEALS2020 speaker John O’Neil, Chief Scientific Officer of Xylyx, a New York-based startup focusing on creating the perfect cell environment for a variety of biotech process including biofabrication/bioprinting, and tissue engineering. Read more >>
20May
Three Investors Offer Fundraising Tips for Early-stage Startups
Three early-stage investors spoke with the Greentown Labs community this month about different types of investors, how to build investor relationships, and advice for approaching fundraising in an uncertain economy. The panel, which was part of Greentown’s Investor Speaker Series, featured Deb Kemper, managing partner of Golden Seeds Ventures, Christopher Mirabile, chair emeritus and public policy chair emeritus of the Angel Capital Association, and Ziad H. Moukheiber, president and CEO of Boston Harbor Angels. Read more >>
19May
The Evolution of Premium Canned Wine
Canned wine isn’t just found on grocery store shelves and at outdoor festivals these days...An increasing awareness of sustainability and wellness among consumers may bolster the positioning of premium canned wine in the marketplace. Organic farming and energy conservation are integral to the philosophy behind canned wine brand Archer Roose, founded in 2015, as does the aluminum package. Read more >>
19May
Aircuity announces new vice president of operations
Aircuity in Newton announced that Tom Nasti joined the company as the vice president of operations. Read more >>
15May
Cruising along: 5 tech firms that are thriving in the pandemic
Wasabi on list. Read more >>
15May
Collaborating on Rare Disease R&D
This week on Growing Greater we learn of rare and serious systemic autoimmune condition known as dermatomyositis. We learn of Corbus Pharmaceuticals’ collaboration with University of Pennsylvania on a Phase 2 study, which has shown positive results. Read more >>
14May
CytoAgents Receives NIH Funding to Accelerate Treatment for Cytokine Storm
CytoAgents awarded $1.6 million National Institutes of Health (NIH) grant to accelerate treatment for cytokine storm. Read more >>
13May
Premama Wellness raises $3.5M in first institutional funding round
Premama Wellness, a Providence-based startup that sells supplements for maternity wellness, has attracted its first institutional investor since launching in 2011: District Ventures Capital, a Canadian venture capital fund hyper-focused on the food, beverage and health and wellness sectors. Read more >>
08May